Sugi Predict

Sugi Predict / Compounds / SCHEMBL1302358

SCHEMBL1302358

SCHEMBL1302358

Cn1c(-c2ccn(C3CC3)n2)nc(-c2ccc(C#N)cc2)c1Sc1ccc(Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 3/20 0.43
▸ MAOA P21397 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ TDP1 Q9NUW8 2/20 0.34
▸ L3MBTL1 Q9Y468 2/20 0.34
▸ PSD A5PKW4 2/20 0.34
▸ LMNA P02545 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ ACHE P22303 1/20 0.33
▸ KDM4C Q9H3R0 1/20 0.33
▸ KIT P10721 1/20 0.33
▸ KDM1A O60341 5/20 0.33
▸ BTK Q06187 1/20 0.33
▸ GAA P10253 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12106886 0.87 FAAH (0.48) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL8011218 0.84 FAAH (0.40) FAAHLMNABTKNPSR1
SCHEMBL1303162 0.84 FAAH (0.45) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL12106878 0.83 FAAH (0.44) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL1303650 0.82 FAAH (0.43) FAAHL3MBTL1LMNAALDH1A1MEN1
SCHEMBL14987925 0.79 FAAH (0.43) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL1303150 0.79 FAAH (0.42) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL8004723 0.79 KDM4C (0.30) KDM4CKDM1A
SCHEMBL1304298 0.79 FAAH (0.67) FAAHMAOAMAOBTDP1L3MBTL1
SCHEMBL8006327 0.79 GAA (0.52) FAAHMAOAMAOBTDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 — — US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 — — US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 — — US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 — — US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 — — US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 — — US disclosed
EP-2300438-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH Merck Sharp & Dohme Corp. (US) 2011-03-30 — — EP disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885MAOA 61/4885MAOB 106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.